Latest 1

European community FP7

Genekam Biotechnology AG has been selected for business mission trip to Tokyo, 26-30 May 2014 under EU GATEWAY TO JAPAN-Healthcare and Medical technologies. Genekam Biotechnology AG is one of 40 companies selected across the European Union.

Genekam got one project for development of Nanoassays for nanomedicine under program ZIM
GENEKAM Biotechnology AG from German Federal Ministry of Economics and Technology.

Genekam is to take part in European Community FP7 ... read more...

Latest 2

ArabLab The Expo 2014

Visit us in Dubai, UAE from 17.03 to 20.03.2014

26. CHINA MED 2014

Visit us in Beijing / VR China 21.03. - 23.03.2014

Medica Düsseldorf 2014

Visit us on Medica 2014 in Düsseldorf from 12.11 to 15.11.2014

Latest 3

New Catalog 2014

Our new Catalog is now released, please download klick here

Latest 4

Hard fact - is it a sign of quality and confidence in our product?

... in 2004 we had clients in 5 countries in whole year and in 2009 we served 60 countries of the world? There is a surge of medical publications where Genekam PCR Kits are being used. Is it not a sign of quality and trust ?

Latest 5

Real time PCR Kits for Influenza A and swine flu (H1N1) (click here to see more information) read more...

Latest 6

In vitro immunisation of human b-lymphocytes and human monoclonal antibodies read more...

Latest 7

Genekam Solutions for combating SARS viruses

Latest 8

Genekam 3D-Stemcell-Solutions

Latest 9

Genekam 解决方案对抗SARS病毒

Latest 10

Genekam-Barcode: Biotech for nature and endangered species
(A new DNA-Test to know the exact species of an animal) read more...


1. Genekam Biotechnoology AG is developing Nanotools on basis of nanoparticles (so called nanocrystals) as they can be used in number of new applications e.g.

  • Serology
  • Flowcytometry
  • Cell tracking
  • Cell labelling
  • Antibody drug conjugates
  • Contrast dyes for imaging system
  • Stem cell
  • Conjugation kits for different ligands
  • Cell enrichment methods

Shortly these products are being released as they are under development.

2. Fluorescent nanoantibodies (DU-Nano) Stem cells biomarkers

Stem cells like mesenchymal stem cells (MSC) can be detected through their biomarkers. Genekam is developing solutions based on nanotechnology so called nanoantibodies (DU-Nano) to detect such biomarkers for stem cells. These nanoantibodies have a number of advantages as they are photostable (so called photobleaching) against the dyes, which bleach within a short time leading to unability to perform the correct assay in flowcytometry or in other instruments. Further they are brighter than dyes and have narrow excitation range and broad emission sprectra. Moreover Genekam products are beyond the state of art. These biomarkers are essential part of detecting the right kind of stem cells otherwise one can have contaminated population of stemcells, which can lead to unwanted results during their therapeutic use as well as other laboratory applications. MSC are immunosuppressive, hence they can be used as therapeutic cellular therapies for cancer and noncancer diseases. These products of Genekam Biotechnology AG have wide applications because they can be used in flow cytometry to detect MSC. MSC can be isolated from different sources like umblical cord blood, peripheral blood, body fat, bone marrow etc.

* only for research use.